Skip to main content

Table 2 Comparison of the demographic and clinical characteristics between training set and test set

From: N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis

  Training (n = 41) Test (n = 20) P
Age (years) 45.0 ± 14.5 44.7 ± 18.2 0.954
Female (%) 26 (63.4%) 11 (55%) 0.528
Diagnosis (%)
 RRMS 21 (51.2%) 11 (55.0%) 0.959
 SPMS 13 (31.7%) 6 (30.0%)  
 PPMS 7 (17.1%) 3 (15.0%)